CPhA Therapeutic Briefs

• Tequin/Tequin I.V. (gatifloxacin): CPhA Update on Tequin (gatifloxacin)'s availability (May 10, 2006)
• Tequin/Tequin I.V. (gatifloxacine) : Mise à jour de l'APhC sur la disponibilité de Tequin (gatifloxacine) (10 mai 2006)
• Recall Notice for Ventolin® Diskus®/ Flovent® Diskus®/ Serevent® Diskus®inhalation devices
• Avis de retrait des Produits inhalateurs Ventolin® Diskus®/ Flovent® Diskus®/Serevent® Diskus®
• Discontinuation of Sales of Nefazodone in Canada
• L'interruption de la commercialisation de la néfazodone au Canada
• Discontinuation of Sales of Nefazodone in Canada: Letter to Pharmacists and Wholesalers
• L'interruption de la commercialisation de la néfazodone au Canada: Lettre destinée aux pharmaciens/pharmaciennes et aux distributeurs.
• "DEET-based insect repellents: safety implications for children and pregnant and lactating women" article from the Canadian Medical Association Journal, August 2003.
• Sunscreen and DEET (PDF)
• Health Canada recently issued a warning about combining certain medications with grapefruit juice. CPhA has a detailed list of drugs known to interact with grapefruit juice and suggested mechanisms for management in the Clin-Info Section of the 2002 CPS.
• Drug Brief: Hormone Replacement Therapy: Recently released studies have left a lot of women concerned about taking HRT. This drug brief is provided by CPhA to assist pharmacists in discussing this issue with their patients. (July 2002)
• Drug Brief: Preparing for Influenza Pandemics; (PDF)
• Drug Brief: U.S. urges Canada to tighten controls on import/export of pseudoephedrine (Jan 2002)